OR WAIT null SECS
Growth and Advancements in Fill/Finish
Employing novel technologies and more patient-centric approaches
Delving into Biopharmaceutical Development and Manufacturing
Quality Considerations in Changing Excipient Providers
October 06, 2022
The UK’s MHRA has approved Colonis’ melatonin oral solution for sleep onset insomnia in children and adolescents with ADHD.
H.I.G. Capital’s portfolio company Aspire Pharma has acquired Morningside Healthcare and Morningside Pharmaceuticals.
Klucel xtend HPC is the latest addition to the company’s Klucel product line and further expands their controlled-release portfolio.
Sponsors should explore key considerations ahead of choosing a new outsourcing partner.
October 05, 2022
Pharmaceutical Technology editors interview oral solid dosage development experts from Syntegon and Colorcon, with discussions centered on continuous OSD production, containment safety, and authentication at the dose level.
Recent technological advancements may have put cleanroom monitoring into a state of flux.
Production of viral vectors requires a holistic view of the product, including its manufacturing process and its ultimate end use.
October 04, 2022
FDA has granted Fast Track designation for CUE-101, a treatment of recurrent/metastatic head and neck squamous cell carcinoma.
Pfizer has completed its acquisition of Biohaven Pharmaceuticals for approximately $11.6 billion.
An expert from Aptamer Group reveals the potential of Optimers (a type of aptamer) in the realm of drug delivery, including its targeting capabilities, scalability, and key differences between Optimers and antibody-drug conjugates.